Publication | Closed Access

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

HepatologyHepatitis CViral HepatitisImmunologyHematologyHepatitisRibavirin-induced Hemolytic AnemiaMedicineChronic Hepatitis CRibavirin Combination Therapy